Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
BMC Ophthalmology|February 24, 2022
Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case reportHajime Onoe, Hiroyuki Shimada, Akiyuki Kawamura, et al.
Journal of Clinical Medicine|February 15, 2022
Safety Measures for Maintaining Low Endophthalmitis Rate after Intravitreal Anti-Vascular Endothelial Growth Factor Injection before and during the COVID-19 PandemicKoji Tanaka, Hiroyuki Shimada, Ryusaburo Mori, et al.
BMC Ophthalmology|June 10, 2020
Bilateral multiple serous retinal detachments after treatment with nivolumab: a case reportReina Miyamoto, Hiroyuki Nakashizuka, Koji Tanaka, et al.
Journal of Clinical Medicine|July 27, 2024
The Evaluation of Change in Choroidal Circulation Time before and after Half-Dose Photodynamic Therapy in Central Serous Chorioretinopathy Using Wide-Field Indocyanine Green AngiographyRuri Sugiyama, Ryusaburo Mori, Akiyuki Kawamura, et al.
Investigative Ophthalmology & Visual Science|September 8, 2011
Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathyKoji Tanaka, Tomohiro Nakayama, Ryusaburo Mori, et al.
BMC Ophthalmology|August 16, 2019
Prospective study of vitrectomy for epiretinal membranes in patients with good best-corrected visual acuityHiroyuki Nakashizuka, Yorihisa Kitagawa, Yu Wakatsuki, et al.
Retina (Philadelphia, Pa.)|April 2, 2015
INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan StudyFumi Gomi, Yuji Oshima, Ryusaburo Mori, et al.
Plos One|December 14, 2023
Maximum carotid intima-media thickness and NT-pro BNP in association with retinal vein occlusionHajime Onoe, Koji Tanaka, Norihiro Tsuchiya, et al.
Scientific Reports|May 30, 2025
Incidence of recurrence and development of polypoidal lesions following half-dose and two-thirds dose photodynamic therapy for pachychoroid neovasculopathyKoji Tanaka, Hajime Onoe, Keigo Takeshima, et al.
Ophthalmology Science|August 20, 2024
Phase I Study of Tivozanib Eye Drops in Healthy Volunteers and Patients with Neovascular Age-Related Macular DegenerationFumi Gomi, Tomohiro Iida, Ryusaburo Mori, et al.
Pageof 10